Authors
Moayad Mosleh, Ahmed Eldesouky, Matthieu Ollivier, Mohamedhen Vall Nounou, Ayham Qatza, Abderraouf Behloul, Omar Hamza, Riccardo D'Ambrosi, Christian Fink, Muhammed Elhadi
Published in
Journal of ISAKOS : joint disorders & orthopaedic sports medicine. Volume 21. Pages 101244. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Graft choice remains a central controversy in primary anterior cruciate ligament reconstruction (ACLR). Quadriceps tendon (QT) and hamstring tendon (HT) autografts may provided similar clinical outcomes but differ in donor-site morbidity and postoperative strength recovery.
To determine whether QT and HT autografts differ in patient-reported outcomes, knee stability, functional performance, strength recovery, donor-site morbidity, and safety after primary ACLR.
PubMed, Scopus, the Cochrane Library, Web of Science, and Embase were searched from inception to March 17, 2026, for randomized controlled trials (RCTs) directly comparing QT and HT autografts. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD420261340928). Random-effects meta-analyses were performed using risk ratios (RRs) for dichotomous outcomes and mean differences (MDs) or standardized mean differences (SMDs) for continuous outcomes, with 95% confidence intervals (CIs). Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool, and certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. No external funding was received.
Fifteen RCTs involving 936 participants were included, with 470 participants receiving QT autografts and 466 receiving HT autografts. Mean ages ranged from 18.7 to 32.7 years, and most studies reported follow-up at 12 or 24 months. At 24 months, no statistically significant differences were detected between QT and HT autografts in IKDC score (MD = -1.19; 95% CI, -3.84 to 1.47; p = 0.38), Lysholm score (MD = 1.42; 95% CI, -0.60 to 3.45; p = 0.17), or Tegner score (MD = -0.15; 95% CI, -0.70 to 0.39; p = 0.58). At the final available follow-up, graft failure occurred in 12 of 265 participants (4.5%) in the QT group and 11 of 261 participants (4.2%) in the HT group, without a statistically significant difference (RR = 1.11; 95% CI, 0.49 to 2.48; p = 0.81). Overall adverse events also showed no statistically significant difference (RR = 0.71; 95% CI, 0.45 to 1.11; p = 0.13). QT autografts were associated with lower donor-site morbidity scores at 24 months (MD = -4.62; 95% CI, -9.21 to -0.03; p = 0.048), although this secondary finding was based on two trials. Knee stability, range of motion, return-to-sport, and hop-test outcomes showed no consistent differences. At 12 months, HT autografts were associated with relatively greater quadriceps strength symmetry, whereas QT autografts were associated with relatively greater hamstring strength symmetry and higher hamstring-to-quadriceps (H/Q) strength ratios.
QT and HT autografts produced similar patient-reported, stability, return-to-sport, and safety outcomes after primary ACLR but demonstrated distinct graft-specific strength-recovery profiles. These findings support individualized graft selection rather than consistent clinical superiority of either graft.
Level II, systematic review, and meta-analysis of RCTs.
PMID:
43033720
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0